Report Detail

Request for Sample of this report

Other Global Autologous Cell Therapy Products Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4555489
    • |
  • 02 September, 2023
    • |
  • Global
    • |
  • Pages: NA
    • |
  • GIR (Global Info Research)
    • |
  • Other

According to our (Global Info Research) latest study, the global Autologous Cell Therapy Products market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
Autologous cell therapy is a medical treatment approach that involves using a patient's own cells to treat a specific medical condition or promote healing. This type of therapy is personalized and based on the principle that cells from the patient's own body are less likely to trigger immune responses or rejection, making it a potentially effective and safe treatment option for various conditions.
The Global Info Research report includes an overview of the development of the Autologous Cell Therapy Products industry chain, the market status of Cancer (Autologous Stem Cell Transplants, Autologous T Cell Therapies), Hemophilia (Autologous Stem Cell Transplants, Autologous T Cell Therapies), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Autologous Cell Therapy Products.
Regionally, the report analyzes the Autologous Cell Therapy Products markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Autologous Cell Therapy Products market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Autologous Cell Therapy Products market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Autologous Cell Therapy Products industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Autologous Stem Cell Transplants, Autologous T Cell Therapies).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Autologous Cell Therapy Products market.
Regional Analysis: The report involves examining the Autologous Cell Therapy Products market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Autologous Cell Therapy Products market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Autologous Cell Therapy Products:
Company Analysis: Report covers individual Autologous Cell Therapy Products manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Autologous Cell Therapy Products This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Cancer, Hemophilia).
Technology Analysis: Report covers specific technologies relevant to Autologous Cell Therapy Products. It assesses the current state, advancements, and potential future developments in Autologous Cell Therapy Products areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Autologous Cell Therapy Products market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Autologous Cell Therapy Products market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Autologous Stem Cell Transplants
Autologous T Cell Therapies
Platelet-Rich Plasma (PRP) Therapy
Others
Market segment by Application
Cancer
Hemophilia
Others
Major players covered
Novartis
Gilead Sciences
Bristol-Myers Squibb
Johnson & Johnson
Autolus Therapeutics
FOSUNKite
JW Therapeutics
CARsgen Therapeutics
Sorrento Therapeutics
Mustang Bio
Cellectis
Allogene Therapeutics
Celyad Oncology
Bluebird Bio
Lonza
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Autologous Cell Therapy Products product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Autologous Cell Therapy Products, with price, sales, revenue and global market share of Autologous Cell Therapy Products from 2018 to 2023.
Chapter 3, the Autologous Cell Therapy Products competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Autologous Cell Therapy Products breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Autologous Cell Therapy Products market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Autologous Cell Therapy Products.
Chapter 14 and 15, to describe Autologous Cell Therapy Products sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Autologous Cell Therapy Products
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Autologous Cell Therapy Products Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Autologous Stem Cell Transplants
    • 1.3.3 Autologous T Cell Therapies
    • 1.3.4 Platelet-Rich Plasma (PRP) Therapy
    • 1.3.5 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Autologous Cell Therapy Products Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Cancer
    • 1.4.3 Hemophilia
    • 1.4.4 Others
  • 1.5 Global Autologous Cell Therapy Products Market Size & Forecast
    • 1.5.1 Global Autologous Cell Therapy Products Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Autologous Cell Therapy Products Sales Quantity (2018-2029)
    • 1.5.3 Global Autologous Cell Therapy Products Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Novartis
    • 2.1.1 Novartis Details
    • 2.1.2 Novartis Major Business
    • 2.1.3 Novartis Autologous Cell Therapy Products Product and Services
    • 2.1.4 Novartis Autologous Cell Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Novartis Recent Developments/Updates
  • 2.2 Gilead Sciences
    • 2.2.1 Gilead Sciences Details
    • 2.2.2 Gilead Sciences Major Business
    • 2.2.3 Gilead Sciences Autologous Cell Therapy Products Product and Services
    • 2.2.4 Gilead Sciences Autologous Cell Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Gilead Sciences Recent Developments/Updates
  • 2.3 Bristol-Myers Squibb
    • 2.3.1 Bristol-Myers Squibb Details
    • 2.3.2 Bristol-Myers Squibb Major Business
    • 2.3.3 Bristol-Myers Squibb Autologous Cell Therapy Products Product and Services
    • 2.3.4 Bristol-Myers Squibb Autologous Cell Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Bristol-Myers Squibb Recent Developments/Updates
  • 2.4 Johnson & Johnson
    • 2.4.1 Johnson & Johnson Details
    • 2.4.2 Johnson & Johnson Major Business
    • 2.4.3 Johnson & Johnson Autologous Cell Therapy Products Product and Services
    • 2.4.4 Johnson & Johnson Autologous Cell Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Johnson & Johnson Recent Developments/Updates
  • 2.5 Autolus Therapeutics
    • 2.5.1 Autolus Therapeutics Details
    • 2.5.2 Autolus Therapeutics Major Business
    • 2.5.3 Autolus Therapeutics Autologous Cell Therapy Products Product and Services
    • 2.5.4 Autolus Therapeutics Autologous Cell Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Autolus Therapeutics Recent Developments/Updates
  • 2.6 FOSUNKite
    • 2.6.1 FOSUNKite Details
    • 2.6.2 FOSUNKite Major Business
    • 2.6.3 FOSUNKite Autologous Cell Therapy Products Product and Services
    • 2.6.4 FOSUNKite Autologous Cell Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 FOSUNKite Recent Developments/Updates
  • 2.7 JW Therapeutics
    • 2.7.1 JW Therapeutics Details
    • 2.7.2 JW Therapeutics Major Business
    • 2.7.3 JW Therapeutics Autologous Cell Therapy Products Product and Services
    • 2.7.4 JW Therapeutics Autologous Cell Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 JW Therapeutics Recent Developments/Updates
  • 2.8 CARsgen Therapeutics
    • 2.8.1 CARsgen Therapeutics Details
    • 2.8.2 CARsgen Therapeutics Major Business
    • 2.8.3 CARsgen Therapeutics Autologous Cell Therapy Products Product and Services
    • 2.8.4 CARsgen Therapeutics Autologous Cell Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 CARsgen Therapeutics Recent Developments/Updates
  • 2.9 Sorrento Therapeutics
    • 2.9.1 Sorrento Therapeutics Details
    • 2.9.2 Sorrento Therapeutics Major Business
    • 2.9.3 Sorrento Therapeutics Autologous Cell Therapy Products Product and Services
    • 2.9.4 Sorrento Therapeutics Autologous Cell Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Sorrento Therapeutics Recent Developments/Updates
  • 2.10 Mustang Bio
    • 2.10.1 Mustang Bio Details
    • 2.10.2 Mustang Bio Major Business
    • 2.10.3 Mustang Bio Autologous Cell Therapy Products Product and Services
    • 2.10.4 Mustang Bio Autologous Cell Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Mustang Bio Recent Developments/Updates
  • 2.11 Cellectis
    • 2.11.1 Cellectis Details
    • 2.11.2 Cellectis Major Business
    • 2.11.3 Cellectis Autologous Cell Therapy Products Product and Services
    • 2.11.4 Cellectis Autologous Cell Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Cellectis Recent Developments/Updates
  • 2.12 Allogene Therapeutics
    • 2.12.1 Allogene Therapeutics Details
    • 2.12.2 Allogene Therapeutics Major Business
    • 2.12.3 Allogene Therapeutics Autologous Cell Therapy Products Product and Services
    • 2.12.4 Allogene Therapeutics Autologous Cell Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Allogene Therapeutics Recent Developments/Updates
  • 2.13 Celyad Oncology
    • 2.13.1 Celyad Oncology Details
    • 2.13.2 Celyad Oncology Major Business
    • 2.13.3 Celyad Oncology Autologous Cell Therapy Products Product and Services
    • 2.13.4 Celyad Oncology Autologous Cell Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Celyad Oncology Recent Developments/Updates
  • 2.14 Bluebird Bio
    • 2.14.1 Bluebird Bio Details
    • 2.14.2 Bluebird Bio Major Business
    • 2.14.3 Bluebird Bio Autologous Cell Therapy Products Product and Services
    • 2.14.4 Bluebird Bio Autologous Cell Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Bluebird Bio Recent Developments/Updates
  • 2.15 Lonza
    • 2.15.1 Lonza Details
    • 2.15.2 Lonza Major Business
    • 2.15.3 Lonza Autologous Cell Therapy Products Product and Services
    • 2.15.4 Lonza Autologous Cell Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Lonza Recent Developments/Updates

3 Competitive Environment: Autologous Cell Therapy Products by Manufacturer

  • 3.1 Global Autologous Cell Therapy Products Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Autologous Cell Therapy Products Revenue by Manufacturer (2018-2023)
  • 3.3 Global Autologous Cell Therapy Products Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Autologous Cell Therapy Products by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Autologous Cell Therapy Products Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Autologous Cell Therapy Products Manufacturer Market Share in 2022
  • 3.5 Autologous Cell Therapy Products Market: Overall Company Footprint Analysis
    • 3.5.1 Autologous Cell Therapy Products Market: Region Footprint
    • 3.5.2 Autologous Cell Therapy Products Market: Company Product Type Footprint
    • 3.5.3 Autologous Cell Therapy Products Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Autologous Cell Therapy Products Market Size by Region
    • 4.1.1 Global Autologous Cell Therapy Products Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Autologous Cell Therapy Products Consumption Value by Region (2018-2029)
    • 4.1.3 Global Autologous Cell Therapy Products Average Price by Region (2018-2029)
  • 4.2 North America Autologous Cell Therapy Products Consumption Value (2018-2029)
  • 4.3 Europe Autologous Cell Therapy Products Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Autologous Cell Therapy Products Consumption Value (2018-2029)
  • 4.5 South America Autologous Cell Therapy Products Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Autologous Cell Therapy Products Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Autologous Cell Therapy Products Sales Quantity by Type (2018-2029)
  • 5.2 Global Autologous Cell Therapy Products Consumption Value by Type (2018-2029)
  • 5.3 Global Autologous Cell Therapy Products Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Autologous Cell Therapy Products Sales Quantity by Application (2018-2029)
  • 6.2 Global Autologous Cell Therapy Products Consumption Value by Application (2018-2029)
  • 6.3 Global Autologous Cell Therapy Products Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Autologous Cell Therapy Products Sales Quantity by Type (2018-2029)
  • 7.2 North America Autologous Cell Therapy Products Sales Quantity by Application (2018-2029)
  • 7.3 North America Autologous Cell Therapy Products Market Size by Country
    • 7.3.1 North America Autologous Cell Therapy Products Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Autologous Cell Therapy Products Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Autologous Cell Therapy Products Sales Quantity by Type (2018-2029)
  • 8.2 Europe Autologous Cell Therapy Products Sales Quantity by Application (2018-2029)
  • 8.3 Europe Autologous Cell Therapy Products Market Size by Country
    • 8.3.1 Europe Autologous Cell Therapy Products Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Autologous Cell Therapy Products Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Autologous Cell Therapy Products Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Autologous Cell Therapy Products Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Autologous Cell Therapy Products Market Size by Region
    • 9.3.1 Asia-Pacific Autologous Cell Therapy Products Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Autologous Cell Therapy Products Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Autologous Cell Therapy Products Sales Quantity by Type (2018-2029)
  • 10.2 South America Autologous Cell Therapy Products Sales Quantity by Application (2018-2029)
  • 10.3 South America Autologous Cell Therapy Products Market Size by Country
    • 10.3.1 South America Autologous Cell Therapy Products Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Autologous Cell Therapy Products Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Autologous Cell Therapy Products Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Autologous Cell Therapy Products Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Autologous Cell Therapy Products Market Size by Country
    • 11.3.1 Middle East & Africa Autologous Cell Therapy Products Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Autologous Cell Therapy Products Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Autologous Cell Therapy Products Market Drivers
  • 12.2 Autologous Cell Therapy Products Market Restraints
  • 12.3 Autologous Cell Therapy Products Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Autologous Cell Therapy Products and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Autologous Cell Therapy Products
  • 13.3 Autologous Cell Therapy Products Production Process
  • 13.4 Autologous Cell Therapy Products Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Autologous Cell Therapy Products Typical Distributors
  • 14.3 Autologous Cell Therapy Products Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Autologous Cell Therapy Products. Industry analysis & Market Report on Autologous Cell Therapy Products is a syndicated market report, published as Global Autologous Cell Therapy Products Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Autologous Cell Therapy Products market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,717.88
    		4,076.82
    		5,435.76
    		3,219.00
    		4,828.50
    		6,438.00
    		545,524.80
    		818,287.20
    		1,091,049.60
    		290,684.40
    		436,026.60
    		581,368.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo